نتائج البحث - Laurent Bedenne

  • يعرض 1 - 19 نتائج من 19
تنقيح النتائج
  1. 1
    Adenoma-carcinoma sequence or “de novo” Carcinogenesis?. A study of adenomatous remnants in a population-based series of large bowel cancers

    Adenoma-carcinoma sequence or “de novo” Carcinogenesis?. A study of adenomatous remnants in a population-based series of large bowel cancers حسب Laurent Bedenne, Jean Faivre, M C Boutron, F Piard, J.-M. Cauvin, Patrick Hillon

    منشور في 1992
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Phase III Trial of Protracted Compared With Split-Course Chemoradiation for Esophageal Carcinoma: Fédération Francophone de Cancérologie Digestive 9102

    Phase III Trial of Protracted Compared With Split-Course Chemoradiation for Esophageal Carcinoma: Fédération Francophone de Cancérologie Digestive 9102 حسب G. Créhange, P. Maingon, Karine Peignaux, Tan Dat Nguyen, X. Mirabel, Christian Marchal, Pierre Verrelle, Bernard Roullet, Franck Bonnetain, Laurent Bedenne

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials

    Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials حسب Sandra Collette, Franck Bonnetain, Xavier Paolettí, Michel Doffoël, Olivier Bouché, Jean‐Luc Raoul, Philippe Rougier, F. Masskouri, Laurent Bedenne, Jean‐Claude Barbare

    منشور في 2008
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery compared with chemoradiation alone in locally advanced squamous resectable thoracic esophageal cancer

    A comparative longitudinal quality of life study using the Spitzer quality of life index in a randomized multicenter phase III trial (FFCD 9102): chemoradiation followed by surgery... حسب Franck Bonnetain, Olivier Bouché, Pierre Michel, C. Mariette, Thierry Conroy, Denis Pezet, Bernard Roullet, J. F. Seitz, B Paillot, Patrick Arveux, C Milan, Laurent Bedenne

    منشور في 2006
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)

    Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO) حسب Christophe Locher, Blaise Batumona, Pauline Afchain, Nicolas Carrère, Emmanuelle Samalin, Christophe Cellier, Thomas Aparicio, Yves Becouarn, Laurent Bedenne, Pierre Michel, Yann Parc, Marc Pocard, Benoist Chibaudel, Olivier Bouché

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

    Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial حسب Marc Ychou, Valérie Boige, Jean‐Pierre Pignon, Thierry Conroy, Olivier Bouché, G. Lebreton, Muriel Ducourtieux, Laurent Bedenne, Jean-Michel Fabre, B. Saint‐Aubert, Jean Genève, P Lasser, P. Rougier

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102

    Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102 حسب Laurent Bedenne, Pierre Michel, Olivier Bouché, Chantal Milan, C. Mariette, Thierry Conroy, Denis Pezet, Bernard Roullet, Jean-François Seitz, Jean-Philippe Herr, B Paillot, Patrick Arveux, Franck Bonnetain, Christine Binquet

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802)

    A phase III randomised trial of LV5FU2 + irinotecan versus LV5FU2 alone in adjuvant high-risk colon cancer (FNCLCC Accord02/FFCD9802) حسب Marc Ychou, Jean‐Luc Raoul, Jean‐Yves Douillard, S. Gourgou-Bourgade, R. Bugat, Laurent Mineur, F. Viret, Y. Bécouarn, Olivier Bouché, E. Gamelin, Michel Ducreux, Thierry Conroy, Julia Seitz, Laurent Bedenne, A. Kramar

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601

    Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: Results from the multicenter, randomised trial... حسب François‐Régis Ferrand, David Malka, Abderrahmane Bourredjem, Caroline Allonier, Olivier Bouché, Samy Louafi, Valérie Boige, M Mousseau, Jean‐Luc Raoul, Laurent Bedenne, Bernard Leduc, Philippe Deguiral, Matthieu Faron, Jean‐Pierre Pignon, Michel Ducreux

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised strategic phase III trial (FFCD 0301)

    Combination 5-fluorouracil, folinic acid and cisplatin (LV5FU2-CDDP) followed by gemcitabine or the reverse sequence in metastatic pancreatic cancer: final results of a randomised... حسب Laëtitia Dahan, Franck Bonnetain, Marc Ychou, Emmanuel Mitry, Mohamed Gasmi, Jean‐Luc Raoul, S. Cattan, Jean-Marc Phélip, Pascal Hammel, Bruno Chauffert, Pierre Michel, Jean-Louis Legoux, P. Rougier, Laurent Bedenne, Jean‐François Seitz

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon α for advanced carcinoid tumors: FNCLCC–FFCD 9710

    Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon α for advanced carcinoid tumors: FNCLCC–FFCD 9710 حسب Laëtitia Dahan, Frank Bonnetain, Philippe Rougier, Jean‐Luc Raoul, Eric Gamelin, Pierre-Luc Etienne, Guillaume Cadiot, Emmanuel Mitry, Denis Smith, F. Cvitkovic, Bruno Coudert, F. Ricard, Laurent Bedenne, Jean‐François Seitz, NULL AUTHOR_ID

    منشور في 2009
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Idarubicin‐loaded beads for chemoembolisation of hepatocellular carcinoma: results of the <scp>IDASPHERE</scp> phase I trial

    Idarubicin‐loaded beads for chemoembolisation of hepatocellular carcinoma: results of the <scp>IDASPHERE</scp> phase I trial حسب Mathieu Boulin, Patrick Hillon, Jean–Pierre Cercueil, Franck Bonnetain, Tienhan Sandrine Dabakuyo‐Yonli, Anne Minello, J L Jouve, Côme Lepage, Marc Bardou, Maëva Wendremaire, Pascal Guérard, Alban Denys, Aurélie Grandvuillemin, Bruno Chauffert, Laurent Bedenne, Boris Guiu

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Randomized Multicenter Phase II Trial of a Biweekly Regimen of Fluorouracil and Leucovorin (LV5FU2), LV5FU2 Plus Cisplatin, or LV5FU2 Plus Irinotecan in Patients With Previously Untreated Metastatic Gastric Cancer: A Fédération Francophone de Cancérologie Digestive Group Study—FFCD 9803

    Randomized Multicenter Phase II Trial of a Biweekly Regimen of Fluorouracil and Leucovorin (LV5FU2), LV5FU2 Plus Cisplatin, or LV5FU2 Plus Irinotecan in Patients With Previously Un... حسب Olivier Bouché, Jean‐Luc Raoul, Franck Bonnetain, Marc Giovannini, Pierre Étienne, Gérard Lledo, Dominique Arsène, J.F. Paitel, Véronique Guerin‐Meyer, Emmanuel Mitry, Bruno Buecher, Marie Christine Kaminsky, Jean François Seitz, Philippe Rougier, Laurent Bedenne, Chantal Milan

    منشور في 2004
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08)

    Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial... حسب Thomas Ruhstaller, Peter Thuss‐Patience, Stefanie Hayoz, S. Schacher, Jorge Riera Knorrenschild, Annelies Schnider, Ludwig Plaßwilm, Wilfried Budach, Wolfgang Eisterer, Hanne Hawle, C. Mariette, Viviane Hess, Walter Mingrone, Michael Montemurro, Michael Girschikofsky, Sven Schmidt, Michael Bitzer, Laurent Bedenne, Peter Brauchli, M. Stahl

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

    Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial حسب Julien Taı̈eb, Josep Tabernero, Enrico Mini, Fabien Subtil, Gunnar Folprecht, Jean-Luc Van Laethem, J. Thaler, John Bridgewater, Lone Nørgård Pétersen, Hélène Blons, Laurence Collette, Eric Van Cutsem, Philippe Rougier, Ramón Salazar, Laurent Bedenne, Jean‐François Emile, Pierre Laurent‐Puig, Côme Lepage

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results

    Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial—PRODIGE 20 study results حسب Thomas Aparicio, Olivier Bouché, Julien Taı̈eb, E. Maillard, Sylvie Kirscher, Pierre-Luc Etienne, Roger Faroux, F. Khemissa Akouz, Farid El Hajbi, C. Locher, Yves Rinaldi, Thierry Lecomte, Sandrine Lavau‐Denès, Mathieu Baconnier, A. Oden-Gangloff, Dominique Genet, Éléna Paillaud, F. Rétornaz, Éric François, Laurent Bedenne

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer

    Clinical Outcome of the ACCORD 12/0405 PRODIGE 2 Randomized Trial in Rectal Cancer حسب Jean‐Pierre Gérard, D. Azria, S. Gourgou-Bourgade, Isabelle Martel‐Lafay, Christophe Hennequin, Pierre-Luc Etienne, V. Vendrely, Éric François, Guy de La Roche, Olivier Bouché, X. Mirabel, Bernard Denis, Laurent Mineur, Jean-François Berdah, Marc-André Mahé, Y. Bécouarn, Olivier Dupuis, Gérard Lledo, Jean‐François Seitz, Laurent Bedenne, Béata Juzyna, Thierry Conroy

    منشور في 2012
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer

    Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer حسب D. Azria, J. Doyen, Marta Jarlier, Isabelle Martel‐Lafay, Christophe Hennequin, Pierre-Luc Etienne, V. Vendrely, Éric François, G. Roche, Olivier Bouché, X. Mirabel, Bernard Denis, Laurent Mineur, Jean-François Berdah, Marc-André Mahé, Y. Bécouarn, Olivier Dupuis, Gérard Lledo, Jean‐François Seitz, Laurent Bedenne, S. Gourgou-Bourgade, Béata Juzyna, Thierry Conroy, J.P. Gérard

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02)

    Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001–02) حسب Thomas Aparicio, Sandrine Lavau‐Denès, Jean-Marc Phélip, E. Maillard, J L Jouve, D. Gargot, Mohamed Gasmi, C. Locher, Xavier Adhoute, Pierre Michel, Faïza Khemissa, Thierry Lecomte, J. Provençal, Gilles Breysacher, Jean-Louis Legoux, Céline Lepère, J Charneau, J Crétin, Laurence Choné, A. Azzedine, Olivier Bouché, Iradj Sobhani, Laurent Bedenne, Emmanuel Mitry, P Amoyal, D. Auby, Jean‐Baptiste Bachet, Mathieu Baconnier, R. Benoit, Olivier Berthelet, Anne Thirot Bidault, Catherine Bineau, Gilbert Bordes, Nadia Bouarioua, É. Boucher, Olivier Boulat, D Cléau, Patrice Couzigou, Emmanuel Cuillerier, Isabelle Cumin, Bernard Denis, F. Di Fiore, V. Derias, J. Ezenfis, R. Faroux, A. Gagnaire, Gilles Gatineau-Sailliant, Beatriz García, Dominique Genet, A. Gueye, Pascal Hammel, J.-P. Lagasse, B. Landi, C. Lepage, Camille Lobry, Catherine Lombard‐Bohas, May Mabro, R Mackiewicz, Juan José Borrero Martín, Xavier Moncoucy, F. Morvan, M. Mozer, Matthias Pauwels, F Petit-Laurent, Philippe Pouderoux, Patricia Prost, A M Queuniet, Mohamed Ramdani, Christine Rebischung, Philippe Rougier, Matthieu Schnee, Jean‐François Seitz, Laëtitia Stefani, Julien Taı̈eb, Éric Terrebonne, Patrick Texereau, J. Thaury, David Tougeron, Achim Weber, F. Ricard, Franck Bonnetain, F. Masskouri, C. Choine, F. Guiliani, G. Le Pessec, H. Fattouh, Nicolas Provost, Cécile Girault, M. Schneider

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: